Noblesville, IN, United States of America

Thomas P Burris


Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Thomas P Burris

Introduction

Thomas P Burris is a notable inventor based in Noblesville, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of three patents to his name, Burris has demonstrated a commitment to advancing medical science.

Latest Patents

Burris's latest patents include innovative compounds such as biologically active 4H-benzo [1,4] oxazin-3-ones. This invention is directed towards compounds that serve as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. The patent also discloses pharmaceutical compositions that can be used to treat conditions such as non-insulin-dependent diabetes mellitus (NIDDM) and obesity. Another significant patent involves benzoxazinone derivatives, which are also useful as PPARγ modulators. Similar to his previous work, this invention includes pharmaceutical compositions and methods for treating NIDDM and obesity.

Career Highlights

Burris is currently associated with Ortho-McNeil Pharmaceutical Corporation, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in creating effective treatments for metabolic disorders.

Collaborations

Throughout his career, Burris has collaborated with notable colleagues such as Philip J Rybczynski and Donald W Combs. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Thomas P Burris is a distinguished inventor whose work in pharmaceuticals has the potential to impact the treatment of significant health conditions. His innovative patents reflect a dedication to improving medical therapies and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…